Medifast, Inc. (MED)

Medifast Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	429.7	602.46	1,072	1,599	1,526	934.84
Revenue Growth (YoY)	-36.29%	-43.80%	-32.94%	4.75%	63.24%	30.99%
Cost of Revenue	118.43	157.84	296.2	458.16	398.49	237.03
Gross Profit	311.27	444.62	775.85	1,140	1,128	697.82
Selling, General & Admin	299.87	424.64	644.85	951.11	906.96	560.86
Research & Development	4.6	4.6	4.6	4.5	4.4	2.8
Operating Expenses	304.47	429.24	649.45	955.61	911.36	563.66
Operating Income	6.8	15.38	126.4	184.81	216.24	134.16
Interest Expense	-	-	-	-0.7	-0.23	-
Interest & Investment Income	5.05	4.8	2.49	-	-	0.25
Other Non Operating Income (Expenses)	2.67	-3.9	-0.1	-0.05	0.12	-0.14
EBT Excluding Unusual Items	14.52	16.29	128.8	184.06	216.13	134.27
Merger & Restructuring Charges	-12.5	-12.5	-	-	-	-
Pretax Income	2.02	3.79	128.8	184.06	216.13	134.27
Income Tax Expense	1.77	1.7	29.38	40.49	52.1	31.41
Earnings From Continuing Operations	0.25	2.09	99.42	143.57	164.03	102.86
Net Income	0.25	2.09	99.42	143.57	164.03	102.86
Net Income to Common	0.25	2.09	99.42	143.57	164.03	102.86
Net Income Growth	-96.61%	-97.90%	-30.75%	-12.47%	59.47%	32.01%
Shares Outstanding (Basic)	11	11	11	11	12	12
Shares Outstanding (Diluted)	11	11	11	11	12	12
Shares Change (YoY)	0.27%	0.39%	-3.15%	-4.55%	-0.31%	-2.20%
EPS (Basic)	0.02	0.19	9.13	12.82	14.01	8.74
EPS (Diluted)	0.02	0.19	9.10	12.73	13.89	8.68
EPS Growth	-97.00%	-97.91%	-28.52%	-8.35%	60.02%	34.99%
Free Cash Flow	0.65	17.02	141.17	177.89	60.34	139.31
Free Cash Flow Per Share	0.06	1.55	12.93	15.78	5.11	11.76
Dividend Per Share	-	-	4.950	6.560	5.680	4.520
Dividend Growth	-	-	-24.54%	15.49%	25.66%	33.73%
Gross Margin	72.44%	73.80%	72.37%	71.34%	73.89%	74.64%
Operating Margin	1.58%	2.55%	11.79%	11.56%	14.17%	14.35%
Profit Margin	0.06%	0.35%	9.27%	8.98%	10.75%	11.00%
Free Cash Flow Margin	0.15%	2.83%	13.17%	11.13%	3.95%	14.90%
EBITDA	20.76	28.09	139.51	195.79	223.05	138.48
EBITDA Margin	4.83%	4.66%	13.01%	12.25%	14.62%	14.81%
D&A For EBITDA	13.96	12.71	13.11	10.98	6.81	4.32
EBIT	6.8	15.38	126.4	184.81	216.24	134.16
EBIT Margin	1.58%	2.55%	11.79%	11.56%	14.17%	14.35%
Effective Tax Rate	87.71%	44.79%	22.81%	22.00%	24.10%	23.39%
Advertising Expenses	-	14.1	3.4	1.7	1.6	4.4

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q